
SIGA Technologies Inc (NASDAQ:SIGA) shares have rallied about 50% since the World Health Organization declared monkeypox a public health emergency of global concern.
SIGA's lead product, TPOXX, is an orally administered antiviral drug for the treatment of smallpox. Monkeypox is in the same virus family as smallpox, but it causes milder symptoms.